Beckman Coulter to Present at Upcoming Healthcare Conferences

Mon, 26 Oct 2009 18:57:00 GMT

ORANGE COUNTY, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that the company will present at the following conferences:

Affymetrix and Beckman Coulter Team Up

Fri, 18 Sep 2009 00:00:00 GMT

Affymetrix and Beckman Coulter have entered into an agreement to offer researchers, co-developed products in microarrays and automated liquid handlers.

Sangamo's Zinc Finger Nuclease Technology Used To Efficiently Mod...

Tue, 08 Sep 2009 17:46:01 GMT

Enables breakthrough in human stem cell manipulation for research and for the development of stem cells as therapeutics

Beckman Coulter, Inc. to Present at Upcoming Healthcare Conferenc...

Mon, 31 Aug 2009 12:00:00 GMT

ORANGE COUNTY, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. , a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that the company will present at the following

Affymetrix and Beckman Coulter Ally to Provide Automated Target-P...

Wed, 26 Aug 2009 00:00:00 GMT

System will include Affymetrix-validated methods developed on Beckman Coulter’s Biomek FXp Dual Arm Multichannel and span array processing and data generation as well.

Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per S...

Mon, 27 Jul 2009 22:15:00 GMT

ORANGE COUNTY, Calif., July 27 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC) announced today that its Board of Directors declared a quarterly dividend payout of seventeen cents ($0.

Beckman Coulter rises following Barclays upgrade

Fri, 20 Mar 2009 05:22:21 GMT

Shares of Beckman Coulter Inc. rose Thursday after a Barclays analyst upgraded the stock, pointing to its dependable supply revenue, and its recent buyout of Olympus Corp.'s lab-based diagnostics business.

ArQule, Inc., Q2 2008 Earnings Call Transcript

Mon, 11 Aug 2008 19:28:25 GMT

ArQule, Inc. (ARQL)Q2 2008 Earnings Call TranscriptComplete Story

Health Net to help Dubai develop health care funding plan

Wed, 02 Apr 2008 18:00:15 GMT

© 2009 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.

Bumrungrad International Hospital Signs Up For Thailand's First I...

Tue, 12 Feb 2008 08:02:45 GMT

PR: Bumrungrad International hospital will raise patient service and safety to new levels when it introduces Thailand's first modern medical lab automation system in 2008. Beckman Coulter's Lab Automation is the same technology used by many world-class hospitals. It reduces lab turnaround tim

Drug Discovery & Development

Glycosan BioSystems’ Extracel-HP hydrogel is a hyaluronan-based, synthetic extracellular matrix containing catalytic amounts of cross-linked heparin.

Beckman Coulter Announces the Creation of Beckman Coulter Genomic...

Beckman Coulter has announced the creation of Beckman Coulter Genomics. The new company, which combines Agencourt Bioscience and the newly acquired Cogenics, offers researchers a single genomic services resource with expanded global capabilities.

Pharmacy Choice - Pharmaceutical News - Beckman Coulter Announces...

The analyzer's efficient, compact design allows laboratories to maximize valuable space. The system comes in three scaleable configurations that allow for future addition of more lasers and fluorescence detectors as the need for complex multi-color flow cytometry expands.

Beckman Coulter Signs Agreements With Adventist Health; Broad Pro...

In late October, Beckman Coulter signed new sole source agreements with Adventist Health to provide a broad range of core laboratory systems and supplies valued at approximately $36 million over six years.

CoulterCounter.com - Press Releases - Coultercounter.com - News -...

To better support our customers in India, we are glad to announce the addition of Parmar Puneet to the Beckman Coulter Particle Characterization team in India.

Beckman Coulter, Inc. Announces the Creation of

Wed, 12 Aug 2009 12:00:00 GMT

"Through the creation of Beckman Coulter Genomics, we have successfully brought together the industry's leading genomic service providers to offer our customers the highest-quality data and analysis," said Richard Creager, Ph.D.

Beckman Coulter, Inc. Announces Pricing of Common Stock Offering

Wed, 20 May 2009 12:00:00 GMT

ORANGE COUNTY, Calif., May 20 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. , a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, today announced that it priced a public offering of shares of its common stock, the proceeds

Beckman Coulter to Shell Out Almost $800M for Olympus’ Lab-Based ...

Fri, 27 Feb 2009 00:00:00 GMT

Beckman Coulter will acquire the diagnostic systems portion of Olympus' life sciences business for ¥77.45 billion, or approximately $799.7 million. The acquisition will broaden Bec

Beckman Coulter Announces FDA Clearance of UniCel(R) DxH 800

Tue, 23 Dec 2008 12:30:00 GMT

/PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify and automate complex biomedical testing, ushers in a new era of cellular analysis with the release of the UniCel(R) DxH 800 Coulter(R) Cellular Analysis System.

Beckman Coulter Investor Events Second Half of 2008

Wed, 10 Sep 2008 16:58:00 GMT

ORANGE COUNTY, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming company presentations and investor events.

Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Mark...

Mon, 18 Aug 2008 12:30:00 GMT

Initiates Clinical Trials Phase of Test Development Program ORANGE COUNTY, Calif., Aug. 18 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC) announced today that it signed an agreement to buy out its U.S. royalty obligation to Nephromics LLC, a Chestnut Hill, Mass.

Beckman Coulter Obtains Full Rights to Nephromics’ Preeclampsia T...

Mon, 18 Aug 2008 00:00:00 GMT

Beckman Coulter has bought its royalty obligations to Nephromics, which covers a preeclampsia test in development. In addition, Beckman Coulter obtained rights to acquire the world

The Long Case for Celgene Corp.

Thu, 07 Aug 2008 14:57:52 GMT

Steve Patterson submits:Medical Stocks have been showing continued strength with the overall market uncertain if the correction has ended or the current uptrend is just a pause before another leg down for the markets. Celgene Corp. (CELG)

Earnings Preview: Celgene Corporation

Wed, 23 Jul 2008 20:15:41 GMT

Celgene Corporation (CELG) is expected to report Q2 earnings before market open Thursday, July 24, with a conference call scheduled for 9:00 a.m. ET.

Beckman Coulter acquires rights to Siemens's HCV

Thu, 01 May 2008 09:40:00 GMT

Beckman Coulter has licensed certain rights to testing for the hepatitis C virus from Siemens Healthcare Diagnostics.

Zibb.com: Beckman Coulter Incorporated (Industry News & Blogs)